InvestorsInvestorsShare InfoFinancial InfoDocuments & PresentationsCompany ProfileAdvisorsCorporate Governance2026 Capital Raise2024 Capital Raise2023 Capital RaiseRegulatory News ArchiveScancell Holdings PLC is an AIM listed companyDocuments & Presentations 5Regulatory News 5Corporate Deck 5Latest News Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced MelanomaAug 19, 2026 Scancell and Neuphoria Therapeutics Announce Merger Agreement and FinancingJul 23, 2026 View All News
Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced MelanomaAug 19, 2026
